Riskpilot← Back to searchSign inGet full accessBONAVISTA AS
ASActiveOrg 881457962Bærumsveien 225C, 1357 BekkestuaMedical specialists activities · NACE 8622Est. 20000 employees
Revenue 2024
NOK 0
EBITDA margin
—
0% vs 2023
Equity ratio
81.3%
Financial strength
Net profit 2024
NOK 288K
-25% vs 2023
| Revenue | NOK 0 | — |
| EBITDA | NOK -29K | +0% |
| Net profit | NOK 288K | -25% |
| Total assets | NOK 4,2M | -4% |
| Equity | NOK 3,4M | +9% |
| Employees | 0 | — |
Legal name
BONAVISTA AS
Org number
881457962
Legal form
Aksjeselskap
NACE code
8622 · Medical specialists activities
Founded
1. februar 2000
Share capital
NOK 169 218
Employees
0
VAT registered
No
Audit selected
No
Last report
2024-12-31
Financial year
January – December
Signatory rights
To styremedlemmer i fellesskap. Styrets leder alene.
Company purpose
Helsetjeneste, produksjon og salg, forskning, informasjon og konsulentvirksomhet, investering og utleie samt deltagelse i annen virksomhet.
Address
Bærumsveien 225C, 1357 Bekkestua
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Revenue | 0 | 0 | 0 | 0 | 0 |
| Staff expenses | −0 | −0 | −0 | −0 | −0 |
| EBITDA | −29 | −29 | −29 | −29 | −29 |
| Depreciation & amort. | −0 | −0 | −0 | −0 | −0 |
| EBIT | −29 | −29 | −29 | −29 | −29 |
| Net financials | 201 | 376 | 369 | 453 | 385 |
| Profit before tax | 172 | 347 | 340 | 424 | 356 |
| Tax | 3 | 165 | 4 | 41 | 68 |
| Net profit | 170 | 182 | 335 | 383 | 288 |
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Total assets | 5 376 | 5 453 | 5 290 | 4 336 | 4 159 |
| Equity | 4 748 | 3 630 | 3 965 | 3 092 | 3 380 |
| Long-term debt | 4 | 4 | 3 | 0 | 0 |
| Short-term debt | 624 | 1 820 | 1 321 | 1 244 | 779 |
| Total debt | 628 | 1 823 | 1 324 | 1 244 | 779 |
EBITDA margin
-2875000.0%
This company
15.8%
Market median
-18196303% vs market
20202024
Equity ratio
81.3%
This company
38.2%
Market median
+113% vs market
20202024
Return on equity
8.5%
This company
18.4%
Market median
-54% vs market
20202024
Net profit margin
28812700.0%
This company
8.1%
Market median
+355712246% vs market
20202024
Asset turnover
0.00×
This company
1.12×
Market median
-100% vs market
20202024
Debt / equity
0.23×
This company
0.62×
Market median
+63% vs market
20202024
- Annual report 2024Filed via Brønnøysundsregistrene · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via Brønnøysundsregistrene · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via Brønnøysundsregistrene · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via Brønnøysundsregistrene · Period 2021-01-01 – 2021-12-31
- Annual report 2020Filed via Brønnøysundsregistrene · Period 2020-01-01 – 2020-12-31
| Name | Role | Member since |
|---|---|---|
| Current (1) | ||
UK Chief Executive Officer | Chief Executive Officer | 2006 |
| Name | Role | Member since |
|---|---|---|
| Current (2) | ||
| Chairman | 2006 | |
| Board of Directors | 2006 | |
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of BONAVISTA AS also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Unni Karin Salvesen | Chief Executive Officer | 0 companies |
| Svein Osmund Salvesen | Chairman | 0 companies |
| Jan Helge Salvesen | Board of Directors | 0 companies |